NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Abstract
If public resources were unlimited, there would be no gaps in health coverage and no real need for voluntary health insurance (VHI). Most health systems face fiscal constraints, however, and VHI is often seen as a way to address these pressures. This study draws from the experiences of 34 countries to assess VHI’s contribution to health spending and to understand its role in Europe and in relation to publicly financed coverage. It looks at who sells VHI, who purchases it and why. It also reviews public policy on VHI at the national and European Union (EU) levels and the related national policy debates.
The analysis shows that, while the markets for VHI vary considerably in size, operation and regulation, the vast majority are small. The substantial markets tend to be the oldest, to have a tradition of non-profit insurers and to be the most heavily regulated to ensure VHI policies are accessible and affordable. The study also suggests that VHI is normally a better way of meeting the population’s health needs than out-of-pocket payments, although there are notable exceptions. VHI can contribute to financial protection, especially where it plays a substitutive and complementary role covering co-payments. Nevertheless, it is a complex, challenging and highly context-specific policy instrument that may undermine other health-system goals, including equitable access, efficiency, transparency and accountability, even where markets are well regulated. Policy-makers should therefore exercise real caution before expanding VHI to fill coverage gaps.
This report is accompanied by a set of country profiles. The study draws on contributions from national experts from the countries in the EU and the European Free Trade Association, and other countries in the WHO European Region.
Contents
- Acknowledgements
- List of abbreviations
- Note
- 1. Introduction
- 2. VHI at a glance
- VHI’s contribution to total spending on health
- VHI’s contribution to private spending on health
- Why do people buy VHI?
- What role does VHI play?
- How many people buy VHI?
- Who buys VHI?
- What is the socioeconomic status of people with VHI?
- Who sells VHI?
- Who can buy VHI and on what terms?
- How do insurers set VHI premiums?
- How do insurers purchase health services?
- How do insurers spend their revenue?
- Who regulates VHI markets?
- How is VHI regulated?
- Tax incentives for VHI
- National policy developments and concerns around VHI
- 3. Why do people buy VHI?
- 4. Who buys VHI?
- 5. How do markets for VHI work?
- 6. Public policy towards VHI
- References
- Appendix A. Data on health spending in the European Region
- Appendix B. Information on the availability of data and on data assumptions made for figures based on WHO
- Appendix C. Country codes
The European Observatory on Health Systems and Policies supports and promotes evidence-based health policy-making through comprehensive and rigorous analysis of health systems in Europe. It brings together a wide range of policy-makers, academics and practitioners to analyse trends in health reform, drawing on experience from across Europe to illuminate policy issues.
The Observatory is a partnership hosted by the WHO Regional Office for Europe, which includes the governments of Austria, Belgium, Finland, Ireland, Norway, Slovenia, Sweden, the United Kingdom and the Veneto Region of Italy; the European Commission; the World Bank; UNCAM (French National Union of Health Insurance Funds); the London School of Economics and Political Science; and the London School of Hygiene & Tropical Medicine. The Observatory has a secretariat in Brussels and it has hubs in London (at LSE and LSHTM) and at the Technical University of Berlin.
All rights reserved. The European Observatory on Health Systems and Policies welcomes requests for permission to reproduce or translate its publications, in part or in full.
The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the European Observatory on Health Systems and Policies concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.
The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the European Observatory on Health Systems and Policies in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.
All reasonable precautions have been taken by the European Observatory on Health Systems and Policies to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the European Observatory on Health Systems and Policies be liable for damages arising from its use. The views expressed by authors, editors, or expert groups do not necessarily represent the decisions or the stated policy of the European Observatory on Health Systems and Policies or any of its partners.
Printed in the United Kingdom
Typeset by Peter Powell
Cover design by M2M
- NLM CatalogRelated NLM Catalog Entries
- Review Voluntary health insurance in Europe: Country experience[ 2016]Review Voluntary health insurance in Europe: Country experienceSagan A, Thomson S. 2016
- Risk equalisation in voluntary health insurance markets: A three country comparison.[Health Policy. 2010]Risk equalisation in voluntary health insurance markets: A three country comparison.Armstrong J, Paolucci F, McLeod H, van de Ven WP. Health Policy. 2010 Nov; 98(1):39-49. Epub 2010 Jul 24.
- Bulgaria health system review.[Health Syst Transit. 2012]Bulgaria health system review.Dimova A, Rohova M, Moutafova E, Atanasova E, Koeva S, Panteli D, van Ginneken E. Health Syst Transit. 2012; 14(3):1-186.
- Improving access to essential health care services: the case of Israel.[Isr J Health Policy Res. 2016]Improving access to essential health care services: the case of Israel.van de Ven WP. Isr J Health Policy Res. 2016; 5:3. Epub 2016 Mar 4.
- Review Everything you always wanted to know about European Union health policies but were afraid to ask: Second, revised edition[ 2019]Review Everything you always wanted to know about European Union health policies but were afraid to ask: Second, revised editionGreer SL, Fahy N, Rozenblum S, Jarman H, Palm W, Elliott HA, Wismar M. 2019
- Voluntary health insurance in Europe: role and regulationVoluntary health insurance in Europe: role and regulation
Your browsing activity is empty.
Activity recording is turned off.
See more...